{"id":"https://openalex.org/W2012613693","doi":"https://doi.org/10.1158/1535-7163.targ-09-a74","title":"Abstract A74: Activation of EGFR by proteasome inhibition requires HB-EGF in pancreatic cancer cells","display_name":"Abstract A74: Activation of EGFR by proteasome inhibition requires HB-EGF in pancreatic cancer cells","publication_year":2009,"publication_date":"2009-12-01","ids":{"openalex":"https://openalex.org/W2012613693","doi":"https://doi.org/10.1158/1535-7163.targ-09-a74","mag":"2012613693"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.targ-09-a74","doi":"https://doi.org/10.1158/1535-7163.targ-09-a74","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.targ-09-a74","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089572805","display_name":"Callum Mortimer Sloss","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Callum M. Sloss","raw_affiliation_strings":["1 Massachusetts General Hospital, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1 Massachusetts General Hospital, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100321360","display_name":"Fang Wang","orcid":"https://orcid.org/0000-0001-7640-3584","observed_orcids":["https://orcid.org/0000-0001-7640-3584"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fang Wang","raw_affiliation_strings":["1 Massachusetts General Hospital, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1 Massachusetts General Hospital, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000260833","display_name":"Michael A. Palladino","orcid":"https://orcid.org/0000-0002-4687-7612","observed_orcids":["https://orcid.org/0000-0002-4687-7612"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Palladino","raw_affiliation_strings":["2 Nereus Pharmaceuticals, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2 Nereus Pharmaceuticals, San Diego, CA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5060478837","display_name":"James C. Cusack","orcid":"https://orcid.org/0000-0002-1430-318X","observed_orcids":["https://orcid.org/0000-0002-1430-318X"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James C. Cusack","raw_affiliation_strings":["1 Massachusetts General Hospital, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1 Massachusetts General Hospital, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"8","issue":"12_Supplement","first_page":"A74","last_page":"A74"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.5264000296592712,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.5264000296592712,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10620","display_name":"Protease and Inhibitor Mechanisms","score":0.23240000009536743,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.12200000137090683,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hb-egf","display_name":"HB-EGF","score":0.9380000233650208},{"id":"https://openalex.org/keywords/egfr-activation","display_name":"EGFR activation","score":0.9819999933242798},{"id":"https://openalex.org/keywords/proteasome-inhibition","display_name":"proteasome inhibition","score":0.9860000014305115},{"id":"https://openalex.org/keywords/pancreatic-ductal-adenocarcinoma","display_name":"pancreatic ductal adenocarcinoma","score":0.9760000109672546},{"id":"https://openalex.org/keywords/chemoresistance","display_name":"chemoresistance","score":0.9800000190734863},{"id":"https://openalex.org/keywords/npi-0052","display_name":"NPI-0052","score":0.968999981880188},{"id":"https://openalex.org/keywords/epidermal-growth-factor","display_name":"epidermal growth factor","score":0.5849999785423279},{"id":"https://openalex.org/keywords/epiregulin","display_name":"epiregulin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/gm6001","display_name":"GM6001","score":0.9919999837875366},{"id":"https://openalex.org/keywords/flip","display_name":"c-FLIP","score":0.5509999990463257},{"id":"https://openalex.org/keywords/anti-apoptotic-signaling","display_name":"anti-apoptotic signaling","score":0.7689999938011169},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7799999713897705}],"concepts":[{"id":"https://openalex.org/C27740335","wikidata":"https://www.wikidata.org/wiki/Q14878333","display_name":"Proteasome","level":2,"score":0.7411060333251953},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.658909797668457},{"id":"https://openalex.org/C2778367456","wikidata":"https://www.wikidata.org/wiki/Q7251235","display_name":"Proteasome inhibitor","level":3,"score":0.6064385771751404},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.598869264125824},{"id":"https://openalex.org/C2777968868","wikidata":"https://www.wikidata.org/wiki/Q14914546","display_name":"Epiregulin","level":5,"score":0.511424720287323},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.5101342797279358},{"id":"https://openalex.org/C2776362946","wikidata":"https://www.wikidata.org/wiki/Q424374","display_name":"Epidermal growth factor","level":3,"score":0.4216388165950775},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4082433581352234},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.3892635703086853},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.37052053213119507},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3118049204349518},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.3023790121078491},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.29187968373298645},{"id":"https://openalex.org/C2780806702","wikidata":"https://www.wikidata.org/wiki/Q14866198","display_name":"Amphiregulin","level":4,"score":0.07185888290405273},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1535-7163.targ-09-a74","doi":"https://doi.org/10.1158/1535-7163.targ-09-a74","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.targ-09-a74","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2092126330","https://openalex.org/W2149835016","https://openalex.org/W881652246","https://openalex.org/W1580444165","https://openalex.org/W2145938349","https://openalex.org/W2903363727","https://openalex.org/W2031328554","https://openalex.org/W1986105561","https://openalex.org/W2114404458","https://openalex.org/W4308714766"],"abstract_inverted_index":{"Abstract":[0],"Resistance":[1],"to":[2,34,116,127,185,202,227,242],"drug":[3],"treatments":[4],"underlies":[5],"the":[6,19,64,73,94,102,111,118,121,137,251],"high":[7],"lethality":[8],"of":[9,29,60,66,90,98,105,108,123,155,165,181,196,208],"pancreatic":[10,30,131,239],"ductal":[11],"adenocarcinoma":[12],"(PDA).":[13],"We":[14,134],"have":[15,41],"previously":[16],"shown":[17],"that":[18,44,136,170,191,215,232,246],"EGFR/HER4":[20],"ligand":[21,166],"HB-EGF":[22,145,156,171,216,233,249],"plays":[23,234],"an":[24,255],"important":[25],"role":[26,237],"in":[27,52,125,130,183,225,238],"chemoresistance":[28,241],"cancer":[31,132,240],"cell":[32],"lines":[33],"various":[35],"chemotherapeutics.":[36],"Additionally":[37,188],"we":[38,114,168,189],"and":[39,88,93,146,159,218,245,250],"others":[40],"recently":[42],"identified":[43],"proteasome":[45,61,128,140,186,204,228,243,252],"inhibition":[46,62,129,244],"is":[47,177,220],"a":[48,152,192,235],"promising":[49],"therapeutic":[50],"option":[51],"this":[53,106,260],"highly":[54,261],"refractory":[55,262],"disease.":[56,263],"The":[57],"pleiotropic":[58],"effects":[59],"include":[63,80],"activation":[65,89,122,180,207,224],"anti-apoptotic":[67,78],"signaling":[68],"pathways":[69,79],"as":[70,72],"well":[71],"expected":[74],"pro-apoptotic":[75],"signals.":[76],"These":[77],"increased":[81],"heat":[82],"shock":[83],"protein":[84],"expression,":[85,167],"cFLIP":[86],"induction":[87],"EGFR,":[91],"AKT":[92],"MAP":[95],"kinases":[96],"all":[97],"which":[99],"can":[100],"reduce":[101],"apoptotic":[103],"potential":[104],"class":[107],"drug.":[109],"In":[110],"current":[112],"study,":[113],"sought":[115],"determine":[117],"mechanism":[119],"behind":[120],"EGFR":[124,182,223],"response":[126,184,226],"cells.":[133],"found":[135,190],"second":[138],"generation":[139],"inhibitor":[141,154,195,205],"NPI-0052":[142],"induced":[143,206],"EGF,":[144],"epiregulin":[147,176],"mRNA":[148],"expression.":[149],"Using":[150],"both":[151,248],"specific":[153],"activity":[157,198],"(crm-197)":[158],"lentiviral":[160],"mediated":[161],"shRNA":[162],"knock":[163],"down":[164],"discovered":[169],"but":[172],"not":[173],"EGF":[174],"or":[175],"required":[178,221],"for":[179,222,259],"inhibition.":[187,229],"broad":[193],"spectrum":[194],"MMP/ADAM":[197],"(GM6001)":[199],"was":[200],"able":[201],"prevent":[203],"EGFR.":[209],"Taken":[210],"together":[211],"these":[212],"results":[213],"indicate":[214],"expression":[217],"cleavage":[219],"This":[230],"suggests":[231],"prominent":[236],"targeting":[247],"may":[253],"make":[254],"effective":[256],"combination":[257],"treatment":[258],"Citation":[264],"Information:":[265],"Mol":[266],"Cancer":[267],"Ther":[268],"2009;8(12":[269],"Suppl):A74.":[270]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2016-06-24T00:00:00"}